FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to a magnetic system which has a structure containing magnetic nanosized particles of formula MIIMIII 2O4, wherein MII=Fe, Co, Ni, Zn, Mn; MIII=Fe, Cr, or maghemite which are functionalized by bifunctional compounds of formula R1-(CH2)n-R2 where n = 2-20, R1 is specified in: CONHOH, CONHOR, PO(OH)2, PO(OH)(OR), COOH, COOR, SH, SR; R2 is an external group, and is specified in: OH, NH2, COOH, COOR; R is an alkyl group or an alkaline metal specified in C1-6-alkyl and K, Na or Li, respectively). The structure also includes a polymer optionally containing a pharmacologically active molecule, and an external pharmacologically active molecule may be specified in anticancer agents, antimicrobial agents, anti-inflammatory agents, immunomodulators, molecules acting on the central nervous system or able to mark cells so as to enable the identification thereof by means of the usual diagnostic detectors. The invention also refers to a method for preparing the nanosized particles of formula MIIMIII 2O4 which consists in adding a metal salt to alcohol, heating to complete solubilisation of salts, adding water to facilitate salt hydrolysis and heating to temperature 150-180°C to prepare a suspension to be then functionalised. The invention also refers to a method for preparing the magnetic system, wherein the functionalised nanoparticles and the pharmacologically active molecules are integrated into the matrix of a water-insoluble polymer, and the prepared structure is continuously and one-stage coated with adequate surfactants.
EFFECT: invention aims at preparing the magnetic system suitable for hyperthermia procedures.
16 cl, 4 tbl, 1 dwg, 26 ex
Title | Year | Author | Number |
---|---|---|---|
MAGNETIC NANOPARTICLES FUNCTIONALISED WITH PYROCATECHOL, PRODUCTION AND USE THEREOF | 2015 |
|
RU2687497C2 |
MAGNETITE IN FORM OF NANOPARTICLES | 2010 |
|
RU2558882C2 |
FUNCTIONALISED NANOPARTICLES, PREPARATION AND USE THEREOF | 2007 |
|
RU2437890C2 |
PHARMACEUTICAL COMPOSITION FOR PREPARING INJECTION SOLUTION WHEN USED IN TREATING MAGNETIC HYPERTHERMIA AND METHOD FOR PREPARING THEREOF | 2019 |
|
RU2742196C1 |
MAGNETIC COMPOSITE SORBENT | 2012 |
|
RU2547496C2 |
MAGNETIC SORBENT, A METHOD FOR ITS PRODUCTION AND A METHOD FOR SEPARATION OF MOLECULES OF NUCLEIC ACIDS | 2017 |
|
RU2653130C1 |
NANOCOMPOSITE MAGNETIC MATERIAL BASED ON A POLYCONJUGATED POLYMER AND A MIXTURE OF MAGNETIC NANOPARTICLES AND A METHOD FOR PRODUCTION THEREOF | 2021 |
|
RU2768158C1 |
NANOCOMPOSITE MAGNETIC MATERIAL AND METHOD OF ITS PRODUCTION | 2017 |
|
RU2663049C1 |
METAL-POLYMER COMPOSITE MATERIAL BASED ON COBALT NANOPARTICLES AND HYPERBRANCHED POLYOLS, HAVING MAGNETIC PROPERTIES, ANTIPROTEINASE AND ANTIMYCOTIC ACTIVITY, AND METHOD FOR PRODUCTION THEREOF | 2023 |
|
RU2819893C1 |
METAL-POLYMER NANOCOMPOSITE MAGNETIC MATERIAL BASED ON POLY-3-AMINO-7-METHYLAMINO-2-METHYLPHENAZINE AND NANOPARTICLES FeO AND METHOD OF ITS PRODUCTION | 2016 |
|
RU2637333C2 |
Authors
Dates
2013-05-10—Published
2007-12-18—Filed